D&A Pharma
79 rue de Miromesnil
Paris
75008
France
Website: http://www.da-pharma.fr/
Email: contact@da-pharma.com
7 articles about D&A Pharma
-
D&A Pharma: New confirmation for sodium oxybate in the treatment of alcohol dependence: a university thesis provides new evidence and explains its efficacy in maintaining abstinence
6/7/2023
While several effective treatments are currently available for the treatment of alcohol withdrawal syndrome, there is an unmet medical need in the abstinence maintenance phase.
-
Sanaria Inc. PfSPZ Vaccine Against Malaria Receives D&A Pharma Fast Track Designation
9/22/2016
-
Allergan Announces D&A Pharma Approval Of Supplemental New Drug Application (Snda) For AVYCAZ (Ceftazidime And Avibactam)
6/23/2016
-
Shire Submits Application To The U.S. D&A Pharma For Approval Of Lifitegrast For Treatment Of Dry Eye Disease In Adults
3/2/2015
-
Taiho Oncology Receives D&A Pharma Fast Track Designation For TAS-102 As A Potential Treatment For Refractory Metastatic Colorectal Cancer
10/20/2014
-
D&A Pharma Signs Licensing And Distribution Agreement With Grupo JUSTE For ALCOVERĀ® In Spain And Central America
10/3/2014
-
D&A Pharma: a Retrospective Study on the Use of ALCOVERĀ® in Italy Confirms the Efficacy of the Drug With 81% of Patients Successfully Detoxified
7/11/2012